Mayo Clinic Proceedings Home

Telestroke in the Time of COVID-19: The Mayo Clinic Experience


      On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic, and in the weeks following, public health organizations, medical associations, and governing bodies throughout the world recommended limiting contact with others to “flatten the curve” of COVID-19. Although both ischemic and hemorrhagic strokes have been reported with COVID-19, there has been anecdotal suggestion of an overall decrease in stroke admissions. To date, the effects of any pandemic on telestroke service lines have not been described. The purpose of this cross-sectional analysis of telestroke activations in the 30 days before and after the declaration of the COVID-19 pandemic is to describe the difference in case volumes of telestroke activations, the characteristics of patients, and treatment recommendations between the 2 time frames. We found a 50.0% reduction in total telestroke activations between the predeclaration group (142 patients) and the postdeclaration group (71 patients). There were no statistically significant differences in age (P=.95), sex (P=.10), diagnosis (P=.26), or regional variations (P=.08) in activation volumes. The percentage of patients for whom we recommended urgent stroke treatment with intravenous alteplase, mechanical thrombectomy, or both decreased from 44.4% (28 of 63) to 33.3% (11 of 33). The reasons for the sunstantial decrease in telestroke activations and urgent stroke treatment recommendations are likely multifactorial but nevertheless underscore the importance of continued public health measures to encourage patients and families to seek emergency medical care at the time of symptom onset.

      Abbreviations and Acronyms:

      COVID-19 (coronavirus disease 2019), ED (emergency department), IV-tPA (intravenous tissue plasminogen activator), NIHSS (National Institutes of Health Stroke Scale), WHO (World Health Organization)
      To read this article in full you will need to make a payment


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mao L.
        • Wang M.
        • Chen S.
        • et al.
        Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv website.
        (Published February 25, 2020. Accessed April 24, 2020)
        • Lyden P.
        American Heart Association/American Stroke Association Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the COVID-19 pandemic.
        Stroke. 2020; 51: 1910-1912
        • Lee S.Y.
        • Khang Y.-H.
        • Lim H.-K.
        Impact of the 2015 Middle East respiratory syndrome outbreak on emergency care utilization and mortality in South Korea.
        Yonsei Med J. 2019; 60: 796-803
        • Paek S.H.
        • Kim D.K.
        • Lee J.H.
        • Kwak Y.H.
        The Impact of Middle East respiratory syndrome outbreak on trends in emergency department utilization patterns.
        J Korean Med Sci. 2017; 32: 1576-1580
        • Zhao J.
        • Rudd A.
        • Liu R.
        Challenges and potential solutions of stroke care during the coronavirus disease 2019 (COVID-19) outbreak.
        Stroke. 2020; 51: 1356-1357
        • Morelli N.
        • Rota E.
        • Terracciano C.
        • et al.
        The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era [letter; published online ahead of print April 14, 2020].
        Eur Neurol. 2020;
        • Garcia S.
        • Albaghdadi M.S.
        • Meraj P.M.
        • et al.
        Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic [letter].
        J Am Coll Cardiol. 2020; 75: 2871-2872
        • Rodríguez-Leor O.
        • Cid-Álvarez B.
        • Ojeda S.
        • et al.
        Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España.
        REC Interv Cardiol. 2020; 2: 82-89